EBIT: Income before interest and taxes.
CAMP4 Therapeutics Corporation (CAMP) had EBIT of $-13.07M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.29M |
|
$-18.33M |
|
-- |
|
$1.29M |
|
$14.37M |
|
$-13.07M |
|
$-5.26M |
|
$-18.33M |
|
$-18.33M |
|
$-18.33M |
|
$-18.33M |
|
$-18.33M |
|
$-18.33M |
|
|
EBIT |
$-13.07M |
$-12.55M |
|
57.92M |
|
57.92M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$102.20M |
|
$1.93M |
|
$3.26M |
|
$105.46M |
|
$16.62M |
|
-- |
|
$57.93M |
|
$74.56M |
|
$30.90M |
|
$30.90M |
|
$30.90M |
|
51.93M |
|
| Cash Flow Statement Financials | |
$-10.98M |
|
-- |
|
$0.06M |
|
$111.76M |
|
$100.83M |
|
$-10.92M |
|
$1.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1010.12% |
|
-1010.12% |
|
-- |
|
-1416.62% |
|
-1416.62% |
|
$-10.98M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-59.32% |
|
-59.32% |
|
-17.38% |
|
-59.32% |
|
$0.60 |
|
$-0.19 |
|
$-0.19 |
|